» Authors » Grant S Schulert

Grant S Schulert

Explore the profile of Grant S Schulert including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 79
Citations 2559
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Matt M, Drozdov D, Bendstrup E, Glerup M, Hauge E, Masmas T, et al.
Lancet Rheumatol . 2024 Dec; PMID: 39718183
Background: Systemic juvenile idiopathic arthritis-related lung disease (sJIA-LD) is a severe complication in patients with treatment-refractory systemic juvenile idiopathic arthritis (sJIA). The objective of this study was to evaluate the...
2.
Macaraeg M, Baker E, Handorf E, Matt M, Baker E, Brunner H, et al.
Arthritis Rheumatol . 2024 Dec; PMID: 39622767
Objective: Syndrome of undifferentiated recurrent fevers (SURF) is characterized by recurrent fevers and autoinflammation without a confirmed molecular diagnosis of a hereditary recurrent fever syndrome, and not fulfilling criteria for...
3.
Maccora I, Altaye M, Greis K, Brunner H, Duell A, Haffey W, et al.
Ocul Immunol Inflamm . 2024 Nov; :1-10. PMID: 39586039
Background: Uveitis is an inflammatory ocular disease secondary to disruption of the retinal pigmented epithelium (RPE) and blood retinal barrier (BRB). Known clinical factors do not accurately predict uveitis risk...
4.
Maccora I, Ebert J, Schulert G, Quinlan-Waters M, Duell A, Huggins J, et al.
Ocul Immunol Inflamm . 2024 Sep; 32(10):2441-2448. PMID: 39254738
Background: Autosomal dominant neovascular inflammatory vitreoretinopathy (NIV), formerly called "ADNIV," is a rare autoinflammatory condition mainly of adulthood caused by mutations in calcium-activated calpain-5 protease (CAPN5). Our aim is to...
5.
Brunner H, Schulert G, Sproles A, Thornton S, Cornejo G, Anton J, et al.
Arthritis Res Ther . 2024 Aug; 26(1):154. PMID: 39217348
No abstract available.
6.
Schulert G, Zhang K
Adv Exp Med Biol . 2024 Aug; 1448:103-119. PMID: 39117810
Secondary hemophagocytic lymphohistiocytosis (sHLH) has historically been defined as a cytokine storm syndrome (CSS) occurring in the setting of triggers leading to strong and dysregulated immunological activation, without known genetic...
7.
Brunner H, Schulert G, Sproles A, Thornton S, Cornejo G, Anton J, et al.
Arthritis Res Ther . 2024 Jun; 26(1):125. PMID: 38918871
Background: Juvenile idiopathic arthritis (JIA) comprises a heterogeneous group of conditions that can cause marked disability and diminished quality of life. Data on predictors of clinical response are insufficient to...
8.
Brunner H, Akikusa J, Al-Abadi E, Bohnsack J, Boteanu A, Chedeville G, et al.
Ann Rheum Dis . 2024 Jun; 83(11):1561-1571. PMID: 38849152
Objectives: We report the safety, tolerability and efficacy of tofacitinib in patients with juvenile idiopathic arthritis (JIA) in an ongoing long-term extension (LTE) study. Methods: Patients (2-<18 years) with JIA...
9.
Correia Marques M, Ombrello M, Schulert G
Expert Rev Clin Immunol . 2024 Apr; 20(9):1053-1064. PMID: 38641907
Introduction: Systemic juvenile idiopathic arthritis (sJIA) is a severe inflammatory condition with onset in childhood. It is sporadic, but elements of its stereotypical innate immune responses are likely genetically encoded...
10.
Rao S, Jing N, Liu X, Lorman V, Maltenfort M, Schuchard J, et al.
Sci Rep . 2023 Nov; 13(1):21005. PMID: 38017007
Multi-system inflammatory syndrome in children (MIS-C) is a severe post-acute sequela of SARS-CoV-2 infection in children, and there is a critical need to unfold its highly heterogeneous disease patterns. Our...